Roadwarden

Moral Anxiety Studio · 2022 · $10.99 · Adventure · deal grade B

Measured on 2026-10-02 07:37 UTC, 4 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

Estimated net residual revenue: $1.8k to $2.8k per month
Opportunity: $4.4k per month at x1.90 dormancy
Estimated lifetime owners: 180.0k
94% positive across 5212 reviews · 33.6 reviews/month

Why it's flagged

Developer silent for 2.1 years
Studio quiet across its whole catalog
Store page localized in only 1 language(s)
Last discounted 0 months ago, 12 sales in the last 12 months

Analyst notes (AI-assisted)

Note written 2026-08-22; the live figures above take precedence over any numbers in it.

A contemplative text-based fantasy RPG about a wanderer exploring a low-fantasy world over 40 days, built on meaningful choices and atmospheric worldbuilding.

Roadwarden has achieved rare critical consensus (94% positive, 5141 reviews) and generated $390k lifetime from a niche text-adventure audience with minimal marketing push. The 2022 release has fallen quiet: zero discounts in 12 months, developer inactive for 23 months, and current monthly residual income ($2.3k/mo) suggests untapped revival potential through targeted re-engagement, merchandising partnerships, or literary adaptation. This is a critically successful indie property waiting for a second wind. Most realistic play: revival.

Risk: Text-adventure and visual-novel genres have narrow commercial appeal; sustained growth requires audience development outside core niche or platform expansion (console, mobile).
Risk: Single developer (Moral Anxiety Studio, now fading) and one-title catalog create knowledge-concentration risk if revival requires engine modification or live service elements.
Risk: 13.6% key-share leakage and prior deep discounting (evident in free_copy_pct) may have trained price-sensitive buyers; full-price positioning could conflict with install-base expectations.

This case as Markdown · Estimates carry ±30-50% error per title.